155 related articles for article (PubMed ID: 32478856)
1. Hepatitis B virus infection and the risk of cancer among the Chinese population.
Tian T; Song C; Jiang L; Dai J; Lin Y; Xu X; Yu C; Ge Z; Ding Y; Wen Y; Liu B; Shao Y; Shi P; Zhu C; Liu Y; Jing S; Wang Z; Hu Z; Li J
Int J Cancer; 2020 Dec; 147(11):3075-3084. PubMed ID: 32478856
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types.
Song C; Lv J; Liu Y; Chen JG; Ge Z; Zhu J; Dai J; Du LB; Yu C; Guo Y; Bian Z; Yang L; Chen Y; Chen Z; Liu J; Jiang J; Zhu L; Zhai X; Jiang Y; Ma H; Jin G; Shen H; Li L; Hu Z;
JAMA Netw Open; 2019 Jun; 2(6):e195718. PubMed ID: 31199446
[TBL] [Abstract][Full Text] [Related]
3. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
6. Association between hepatitis B virus and pancreatic cancer.
Hassan MM; Li D; El-Deeb AS; Wolff RA; Bondy ML; Davila M; Abbruzzese JL
J Clin Oncol; 2008 Oct; 26(28):4557-62. PubMed ID: 18824707
[TBL] [Abstract][Full Text] [Related]
7. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.
Hsing AW; Zhang M; Rashid A; McGlynn KA; Wang BS; Niwa S; Ortiz-Conde BA; Goedert JJ; Fraumeni JF; O'Brien TR; Gao YT
Int J Cancer; 2008 Apr; 122(8):1849-53. PubMed ID: 18076042
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis.
Wang Y; Yang S; Song F; Cao S; Yin X; Xie J; Tu X; Xu J; Xu X; Dong X; Lu Z
Eur J Cancer Prev; 2013 Jul; 22(4):328-34. PubMed ID: 23165286
[TBL] [Abstract][Full Text] [Related]
13. Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk.
Yang Y; Gao J; Tan YT; Li HL; Wang J; Ma X; Zheng W; Shu XO; Xiang YB
J Gastroenterol Hepatol; 2018 May; 33(5):1131-1137. PubMed ID: 29065440
[TBL] [Abstract][Full Text] [Related]
14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
[TBL] [Abstract][Full Text] [Related]
17. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Franceschi S; Lise M; Trépo C; Berthillon P; Chuang SC; Nieters A; Travis RC; Vermeulen R; Overvad K; Tjønneland A; Olsen A; Bergmann MM; Boeing H; Kaaks R; Becker N; Trichopoulou A; Lagiou P; Bamia C; Palli D; Sieri S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Peeters PH; Rodríguez L; Barroso LL; Dorronsoro M; Sánchez MJ; Navarro C; Barricarte A; Regnér S; Borgquist S; Melin B; Hallmans G; Khaw KT; Wareham N; Rinaldi S; Hainaut P; Riboli E; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):208-14. PubMed ID: 21098651
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
19. Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES).
Wang H; Chen XZ; Chen XL; Zhang WH; Liu K; Wang YJ; Tang HR; Hu JK;
Cancer Med; 2021 Jun; 10(11):3741-3755. PubMed ID: 33934530
[TBL] [Abstract][Full Text] [Related]
20. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
